
NovoCure Limited NVCR
$ 13.3
-2.64%
Quarterly report 2025-Q2
added 07-24-2025
Country |
|
IPO year |
2015 |
Industry |
Health care |
Stock Exchange |
NASDAQ GLOBALSPB |
Shares |
108 M |
Market Cap[1] |
$ 1.43 B |
EBITDA (LTM) |
$ -131 M |
P/E (LTM) |
-10.87 |
P/S (LTM) |
2.39 |
EPS (LTM) |
-1.26 |
Other stocks of industry "Health care"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Cigna Corporation
CI
|
$ 273.87 | 0.59 % | $ 75 B | NYSE,SPB | ||
|
Triple-S Management Corporation
GTS
|
- | 0.28 % | $ 847 M | NYSE | ||
|
Magellan Health, Inc.
MGLN
|
- | -0.19 % | $ 2.49 B | Nasdaq Global Select Market,SPB | ||
|
Anthem
ANTM
|
- | -2.32 % | $ 107 B | NYSE,SPB | ||
|
Humana
HUM
|
$ 268.21 | 0.65 % | $ 32.3 B | NYSE,SPB | ||
|
Centene Corporation
CNC
|
$ 40.83 | 0.91 % | $ 21.3 B | NYSE,SPB | ||
|
CVS Health Corporation
CVS
|
$ 78.97 | -2.3 % | $ 99.4 B | NYSE,SPB | ||
|
Molina Healthcare
MOH
|
$ 168.9 | 1.2 % | $ 9.69 B | NYSE,SPB | ||
|
UnitedHealth Group Inc.
UNH
|
$ 340.98 | 1.26 % | $ 314 B | NYSE,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.